Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Condition:   Glioblastoma Interventions:   Drug: Ibrutinib;   Radiation: Radiation;   Drug: Temozolomide (TMZ) Sponsor:   Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials